Codi QR

A Systematic Review of Botulinum Toxin Injection in Pediatric Dystonia

Botulinum toxin (BT), a first-line treatment for focal dystonias in adults, has gained USA Food and Drug Administration approval for pediatric upper and lower extremity spasticity and sialorrhea, though its use in children younger than 2 years old is still considered off-label treatment for all path...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Andrea Rasera, Giovanna Maddalena Squintani, Maria Angela Cerruto
Format: Artigo
Idioma:Inglês
Publicat: MDPI AG 2024-06-01
Col·lecció:Toxins
Matèries:
Accés en línia:https://www.mdpi.com/2072-6651/16/7/289
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!